{
    "clinical_study": {
        "@rank": "77123", 
        "arm_group": [
            {
                "arm_group_label": "1 BI 201335", 
                "arm_group_type": "Experimental", 
                "description": "low dose"
            }, 
            {
                "arm_group_label": "2 BI 201335", 
                "arm_group_type": "Experimental", 
                "description": "high dose"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of the current study is to investigate the relative bioavailability of two\n      different doses of BI 201335, administered as soft gelatine capsule in comparison to the\n      equivalent doses of three different oral solution per dose of BI 201335."
        }, 
        "brief_title": "Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n        1. Healthy male and female subjects\n\n        Exclusion criteria:\n\n        Any relevant deviation from healthy conditions"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "56", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01764945", 
            "org_study_id": "1220.46", 
            "secondary_id": "2012-000687-22"
        }, 
        "intervention": [
            {
                "arm_group_label": "1 BI 201335", 
                "description": "soft gelatine capsule, oral administration", 
                "intervention_name": "BI 201335 (Reference)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "1 BI 201335", 
                "description": "oral solution 3", 
                "intervention_name": "BI 201335 (Test)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "2 BI 201335", 
                "description": "oral solution 3", 
                "intervention_name": "BI 201335 (Test)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "1 BI 201335", 
                "description": "oral solution 2", 
                "intervention_name": "BI 201335 (Test)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "2 BI 201335", 
                "description": "soft gelatine capsule, oral administration", 
                "intervention_name": "BI 201335 (Reference)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "2 BI 201335", 
                "description": "oral solution 1", 
                "intervention_name": "BI 201335 (Test)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "1 BI 201335", 
                "description": "oral solution 1", 
                "intervention_name": "BI 201335 (Test)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "2 BI 201335", 
                "description": "oral solution 2", 
                "intervention_name": "BI 201335 (Test)", 
                "intervention_type": "Drug"
            }
        ], 
        "lastchanged_date": "October 31, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Biberach", 
                    "country": "Germany"
                }, 
                "name": "1220.46.1 Boehringer Ingelheim Investigational Site"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Relative Bioavailability of BI 201335 (Capsule) Compared to Three Different Oral Solutions of BI 201335 Following Oral Administration in Healthy Male and Female Volunteers (an Open-label, Randomised, Single-dose, Four-way Crossover Study)", 
        "overall_official": {
            "affiliation": "Boehringer Ingelheim", 
            "last_name": "Boehringer Ingelheim", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Maximum measured concentration of the analyte in plasma", 
                "safety_issue": "No", 
                "time_frame": "up to 6 days postdose"
            }, 
            {
                "measure": "Area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity", 
                "safety_issue": "No", 
                "time_frame": "up to 6 days postdose"
            }, 
            {
                "measure": "Area under the concentration-time curve of the analyte in plasma over the time interval from 0 to the time of the last quantifiable data point", 
                "safety_issue": "No", 
                "time_frame": "up to 6 days postdose"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01764945"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Boehringer Ingelheim", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boehringer Ingelheim", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}